CLINICAL_TRIALS
trial_result
· 2015-04-22
Clinical Trial Update: Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance [Phase 3]
Summary
A Phase 3 trial evaluating early, systematic thyroid hormone replacement after radioactive iodine ablation in Graves' disease and its impact on quality of life,…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Graves Disease (Basedow's Disease) | Phase 3 | Status: COMPLETED